Influence of HLA-DQA1*05 Genotype in Adults With Anti-TNF Treatment With Proactive Therapeutic Drug Monitoring.

NCT05986903 · clinicaltrials.gov ↗

UNKNOWN

Status

280

Enrollment

OTHER

Sponsor class

Conditions

Drug Monitoring
Inflammatory Bowel Diseases

Interventions

DRUG: Tumor necrosis factor (TNF)-alpha inhibitors

Sponsor

Hospital del Rio Hortega

Collaborators

[object Object]
[object Object]